fusion pharm inc - FSPM

FSPM

Close Chg Chg %
0.00 0.00 0.00%

Closed Market

0.00

0.00 (0.00%)

Volume: 1.10K

Last Updated:

Feb 4, 2026, 3:55 PM EDT

Company Overview: fusion pharm inc - FSPM

FSPM Key Data

Open

$0.00

Day Range

0.00 - 0.00

52 Week Range

0.00 - 0.00

Market Cap

$0.00

Shares Outstanding

12.59M

Public Float

N/A

Beta

-442.36

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$77,714,285.71

Yield

N/A

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

4.69K

 

FSPM Performance

1 Week
 
0.00%
 
1 Month
 
0.00%
 
3 Months
 
0.00%
 
1 Year
 
9,900.00%
 
5 Years
 
N/A
 

FSPM Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About fusion pharm inc - FSPM

Fusion Pharm, Inc. engages in the development and integration of a line of cultivation containers. It manufactures a line of hydroponic cultivation systems called PharmPods. The company was founded by Scott M. Dittman on November 6, 1990 and is headquartered in Commerce City, CO.

FSPM At a Glance

Fusion Pharm, Inc.
5850 East 58th Avenue
Commerce City, Colorado 80022
Phone 1-303-287-9013 Revenue 0.00
Industry Other Consumer Specialties Net Income -2,570,627.00
Sector Consumer Durables Employees 16
Fiscal Year-end 12 / 1999
View SEC Filings

FSPM Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio N/A
Price to Book Ratio 8.096
Price to Cash Flow Ratio 0.11
Enterprise Value to EBITDA -9.531
Enterprise Value to Sales N/A
Total Debt to Enterprise Value 0.855

FSPM Efficiency

Revenue/Employee N/A
Income Per Employee -160,664.188
Receivables Turnover N/A
Total Asset Turnover N/A

FSPM Liquidity

Current Ratio 1.007
Quick Ratio 1.007
Cash Ratio 0.121

FSPM Profitability

Gross Margin N/A
Operating Margin N/A
Pretax Margin N/A
Net Margin N/A
Return on Assets N/A
Return on Equity N/A
Return on Total Capital -11.959
Return on Invested Capital N/A

FSPM Capital Structure

Total Debt to Total Equity 3,266.404
Total Debt to Total Capital 97.029
Total Debt to Total Assets 82.824
Long-Term Debt to Equity 3,266.404
Long-Term Debt to Total Capital 97.029
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Fusion Pharm Inc - FSPM

Collapse All in section
All values USD millions. 1998 5-year trend
Sales/Revenue
- - - -
-
Sales Growth
- - - -
-
Cost of Goods Sold (COGS) incl D&A
- - - -
-
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
- - - 2.56K
-
Depreciation
- - - -
-
Amortization of Intangibles
- - - -
-
COGS Growth
- - - -
-
Gross Income
- - - -
-
Gross Income Growth
- - - -
-
Gross Profit Margin
- - - -
-
1998 5-year trend
SG&A Expense
- - - 558.02K
-
Research & Development
- - - -
-
Other SG&A
- - - 558.02K
-
SGA Growth
- - - +0.56%
-
Other Operating Expense
- - - -
-
Unusual Expense
- - - -
-
EBIT after Unusual Expense
- - - (560.58K)
-
Non Operating Income/Expense
- - - 170
-
Non-Operating Interest Income
- - - 170
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
- - - (560.41K)
-
Pretax Income Growth
- - - -0.56%
-
Pretax Margin
- - - -
-
Income Tax
- - - -
-
Income Tax - Current - Domestic
- - - -
-
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
- - - (560.41K)
-
Minority Interest Expense
- - - -
-
Net Income
- - - (560.41K)
-
Net Income Growth
- - - -0.56%
-
Net Margin Growth
- - - -
-
Extraordinaries & Discontinued Operations
- - - (2.01M)
-
Discontinued Operations
- - - (2.01M)
-
Net Income After Extraordinaries
- - - (2.57M)
-
Preferred Dividends
- - - -
-
Net Income Available to Common
- - - (2.57M)
-
EPS (Basic)
- - - -74857142.8571
-
EPS (Basic) Growth
- - - -74,857,142.86%
-
Basic Shares Outstanding
- - - 0.034370000000000005
-
EPS (Diluted)
- - - -74857142.8571
-
EPS (Diluted) Growth
- - - -74,857,142.86%
-
Diluted Shares Outstanding
- - - 0.034370000000000005
-
EBITDA
- - - (558.02K)
-
EBITDA Growth
- - - -0.56%
-
EBITDA Margin
- - - -
-

Fusion Pharm Inc in the News